GlassScriptPhysician profile
Michael Joseph Thomas
NPI 1003114638
$994.57
in general payments reported to CMS, 2019-2025
18 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.40 · 2022: $168 · 2023: $269 · 2024: $310 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $124.37 | 2022-2025 | |
| Qol Medical, LLC | $123.55 | 2023 | Sucraid |
| Alcresta Therapeutics, INC. | $120.08 | 2022 | |
| Servier Pharmaceuticals LLC | $96.61 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.70 | 2023-2025 | Gattex, Advate |
| Alexion Pharmaceuticals, INC. | $65.40 | 2023-2025 | Ultomiris, Koselugo |
| Abbott Laboratories | $64.37 | 2024 | Diamondback Coronary |
| Regeneron Healthcare Solutions, INC. | $60.28 | 2022-2023 | Dupixent |
| Medunik USA INC. | $48.08 | 2024-2025 | Siklos |
| Agios Pharmaceuticals, INC. | $40.93 | 2024 | Pyrukynd |
| Nestle Healthcare Nutrition INC. | $31.57 | 2023 | |
| Travere Therapeutics, INC. | $27.17 | 2023 | Cholbam |
| Rare Disease Therapeutics, INC. | $23.35 | 2025 | Xromi |
| Springworks Therapeutics, INC. | $23.05 | 2025 | Gomekli |
| Pfizer INC. | $19.26 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $17.40 | 2021 | |
| Tempus Ai, INC | $16.69 | 2025 | Xt Cdx |
| Bayer Healthcare Pharmaceuticals INC. | $13.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.